is scientific director in the staff unit "International and European Affairs" of the Federal Institute for Drugs and Medical Devices (BfArM). He heads the unit "Scientific Quality in European Procedures" and is responsible for the coordination of content assessments of marketing authorization dossiers.
He is a nominated German member of the Quality Working Party of the European Medicines Agency (EMA). He is also a member of the PAT Expert Group of the EDQM in Strasbourg and of the PAT Team of the EMA in London.
After obtaining his PhD in Pharmaceutical Chemistry, he worked for two years as a post-doctoral fellow at the University of Florida, USA. He joined the BfArM in 1990, first as a quality assessor, then as head of a laboratory division. From 1995 to 2005, he was head of the "Technology of solid dosage forms" section of the pharmaceutical quality department, and from 2005 to 2011, he was head of the interdisciplinary "Cardiovascular" section. His scientific work focuses on analytical and technological issues. He was a member of the Bioavailability Commission and participates in the Pharmaceutical Technology Committee of the German Pharmacopoeia. In addition to his work in regulatory affairs, he prepares and comments on national and international guidelines and monograph drafts of the European Pharmacopoeia.